Peter R. Galbraith, M.D.; Leslie S. Valberg, M.D.; Peter H. Gruner, M.D.; G. Malcolm Brown, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
Leukokinetic studies were performed in 11 subjects with chronic myelogenous leukemia (CML) by labeling leukocytes in vitro with diisopropyl fluorophosphate and returning them to the circulation. In contrast to normal subjects, in whom leukocytes disappeared in a random fashion with a mean half time (T ½) of 6.44 hours, the average T ½ of CML leukocytes was 106 hours. Normal isologous leukocytes transfused into CML subjects survived normally. Analysis of the leukocyte survival data indicated that the persistance of labeled immature cells could not account for the total amount of leukocyte radioactivity that remained in the blood for prolonged periods.
Learn more about subscription options.
Register Now for a free account.
Galbraith PR, Valberg LS, Gruner PH, Brown GM. The Mechanism of the Leukocytosis in Chronic Myelogenous Leukemia.. Ann Intern Med. 1965;62:1085. doi: 10.7326/0003-4819-62-5-1085_2
Download citation file:
Published: Ann Intern Med. 1965;62(5):1085.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only